- In November 2023, Bracco formed a partnership with ulrich medical to introduce syringeless magnetic resonance injectors. This collaboration enabled Bracco to launch its product in the U.S. market, marking a significant step toward enhancing MR imaging capabilities
- In November 2022, GE Healthcare and ulrich medical joined forces to offer multi-dose contrast media injectors in the U.S. These injectors are designed to deliver iodinated contrast media for CT imaging procedures, streamlining the procedure setup and boosting patient throughput
- In November 2022, GE Healthcare announced a major investment of USD 80 million to enhance its contrast media production capacity. By 2025, the company aims to produce an additional 30 million doses of contrast media annually, which is expected to significantly contribute to the growth of the market
- In December 2021, Guerbet and Bracco Imaging entered into a global collaboration for the development of Gadopiclenol, a next-generation magnetic resonance imaging (MRI) contrast agent. This partnership is set to advance MRI imaging with improved contrast quality
- In December 2021, Qaelum NV announced a strategic partnership with Ulrich GmbH & Co. KG in Ulm to integrate their advanced Contrast Management solution with Ulrich Medical’s contrast media injectors. This collaboration aims to meet the evolving needs of hospitals and imaging networks, enhancing overall imaging efficiency
